MedTrace Logo

Feasibility of a Wearable-enabled Intervention for Promoting Physical Activity in People Knee OA

NCT02313506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2019-11-19

Study results available
· View outcomes & findings →

Summary

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, a 2013 systematic review found only 13% met the activity recommendation of 150 minutes or more per week. The primary goal of this pilot randomized controlled trail is to assess the feasibility and preliminary efficacy of a multi-component intervention/model of care involving a group education session, use of the Fitbit Flex (a wireless physical activity tracking device), and weekly telephone counselling by a physiotherapist (PT) to improve physical activity and reduce sedentary time in patients with knee OA.

Conditions

Interventions

BEHAVIORAL

Education session, Fitbit Flex, and remote coaching by a PT

Participants will receive a brief education session, use of a commercially available physical activity tracker (Fitbit Flex), and remote counselling by a PT. Intervention will be received immediately.

BEHAVIORAL

Same intervention with a 1 month delay

The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 1 Month delay.

Sponsors & Collaborators

  • Arthritis Research Centre of Canada

    collaborator OTHER

  • Vancouver General Hospital

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Linda Li, PT, PhD · Arthritis Research Canada; University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313506 on ClinicalTrials.gov